1. Home
  2. CERT vs OXLC Comparison

CERT vs OXLC Comparison

Compare CERT & OXLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERT
  • OXLC
  • Stock Information
  • Founded
  • CERT 2008
  • OXLC 2010
  • Country
  • CERT United States
  • OXLC United States
  • Employees
  • CERT N/A
  • OXLC N/A
  • Industry
  • CERT Retail: Computer Software & Peripheral Equipment
  • OXLC Investment Managers
  • Sector
  • CERT Technology
  • OXLC Finance
  • Exchange
  • CERT Nasdaq
  • OXLC Nasdaq
  • Market Cap
  • CERT 1.9B
  • OXLC 1.8B
  • IPO Year
  • CERT 2020
  • OXLC N/A
  • Fundamental
  • Price
  • CERT $11.60
  • OXLC $5.10
  • Analyst Decision
  • CERT Buy
  • OXLC Strong Buy
  • Analyst Count
  • CERT 7
  • OXLC 1
  • Target Price
  • CERT $15.92
  • OXLC $6.00
  • AVG Volume (30 Days)
  • CERT 1.3M
  • OXLC 1.9M
  • Earning Date
  • CERT 11-06-2024
  • OXLC 11-01-2023
  • Dividend Yield
  • CERT N/A
  • OXLC 18.86%
  • EPS Growth
  • CERT N/A
  • OXLC N/A
  • EPS
  • CERT N/A
  • OXLC 1.20
  • Revenue
  • CERT $372,797,000.00
  • OXLC $130,145,365.00
  • Revenue This Year
  • CERT $10.20
  • OXLC $136.15
  • Revenue Next Year
  • CERT $10.43
  • OXLC $5.51
  • P/E Ratio
  • CERT N/A
  • OXLC $4.24
  • Revenue Growth
  • CERT 5.62
  • OXLC N/A
  • 52 Week Low
  • CERT $9.41
  • OXLC $4.41
  • 52 Week High
  • CERT $19.87
  • OXLC $5.70
  • Technical
  • Relative Strength Index (RSI)
  • CERT 55.62
  • OXLC 29.80
  • Support Level
  • CERT $11.05
  • OXLC $5.02
  • Resistance Level
  • CERT $11.83
  • OXLC $5.31
  • Average True Range (ATR)
  • CERT 0.50
  • OXLC 0.05
  • MACD
  • CERT 0.06
  • OXLC -0.01
  • Stochastic Oscillator
  • CERT 63.87
  • OXLC 25.86

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

About OXLC Oxford Lane Capital Corp.

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

Share on Social Networks: